Metoclopramide Injection 5 mg/ml Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 5 mg/ml
Reference Brands: Maxolon (EU/UK)
Category: Antiemetic
Metoclopramide injection (5 mg/ml) prevents and treats nausea and vomiting, including after surgery and from migraine, and speeds stomach emptying. Treatment is limited to short courses because of the risk of movement disorders. Reference brands include Maxolon and Reglan. PharmaTradz sources it for importers, hospitals and tenders, and shares GMP certificates and CoA before you commit.
Manufacture or export Metoclopramide Injection? List it or send an offer →
Product Description:
Metoclopramide Injection contains Metoclopramide as an active ingredient. Metoclopramide Injection works by controlling vomiting sensations and speeds up emptying of stomach.
Metoclopramide is a dopamine D2 receptor antagonist widely used to manage nausea and vomiting associated with gastroesophageal reflux disease (GERD), diabetic gastroparesis, and chemotherapy. By enhancing gastric motility and accelerating gastric emptying, it helps relieve symptoms of delayed gastric emptying and improves gastrointestinal function. It is also used prophylactically to prevent nausea and vomiting in postoperative patients when nasogastric suction is not feasible.
While primarily approved by the FDA for gastrointestinal motility disorders and chemotherapy-induced nausea, metoclopramide has also demonstrated effectiveness in other conditions such as migraine management, although these uses are considered off-label. Its pharmacological action involves antagonism of dopamine receptors in the chemoreceptor trigger zone and gastrointestinal tract, contributing to both antiemetic and prokinetic effects.
Metoclopramide therapy requires careful monitoring due to potential adverse effects, including extrapyramidal symptoms, tardive dyskinesia, and sedation. Understanding its mechanism of action, appropriate dosing, contraindications, and possible drug interactions is essential for healthcare professionals to optimize patient outcomes while minimizing risks. This makes metoclopramide a valuable option in the clinical management of nausea, vomiting, and gastrointestinal motility disorders.
Metoclopramide Injection — third party manufacturing & bulk supply
Metoclopramide Injection 5 mg/ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Metoclopramide Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Metoclopramide Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Metoclopramide Injection →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Metoclopramide is used to treat nausea and vomiting, delayed gastric emptying (gastroparesis), and to improve gastrointestinal motility. It is also prescribed to prevent nausea and vomiting caused by chemotherapy or surgery.
The active ingredient is metoclopramide hydrochloride, formulated with excipients suitable for oral or injectable administration.
Common trade names include Reglan® and region-specific generic formulations.
It is manufactured by multiple pharmaceutical companies worldwide, including Sanofi (Reglan®) and licensed generic manufacturers in India, Europe, and the Middle East.
The generic name is Metoclopramide.
Brand examples include Reglan, Maxolon and generics available in different regions.
Metoclopramide is manufactured in GMP-certified pharmaceutical facilities globally, including the USA, Europe, India, and the Middle East, for both oral and injectable forms.
European regulators limit use to 5 days at a maximum of 30 mg a day (0.5 mg/kg in adults) because of the risk of movement disorders.
Only as second-line treatment for post-operative or chemotherapy vomiting in children over 1 year, in Europe.
5 mg/ml in 2 ml ampoules, given slowly over at least 3 minutes.
Related Products
Metoclopramide Hydrochloride Drops
Strength:
1 mg/ml, 4.14 mg/ml
Form: Drops
Reference Brands: Metocol (India), Premosan (UAE), Metowell
View DetailsPromethazine Tablets
Strength:
10 mg, 25 mg
Form: Tablets
Reference Brands: Phenergan (USA), Avomine (EU)
View DetailsDomperidone Suspension
Strength:
1 mg/ml
Form: Suspension
Reference Brands: Motilium Suspension (LATAM), Domstal Suspension (India/LATAM)
View DetailsDomperidone Tablets
Strength:
10 mg, 20 mg
Form: Tablet
Reference Brands: Motilium(EU), Vomistop (India), Domperix (LATAM)
View DetailsCyclizine Tablet
Strength:
50 mg
Form: Tablets
Reference Brands: Marezine, Cyclivert, and Bonine(US)
View DetailsMeclizine Tablet
Strength:
25 mg
Form: Tablets
Reference Brands: Antivert, Bonine, Dramamine(US)
View DetailsDimenhydrinate Tablets
Strength:
50 mg, 100 mg
Form: Tablets
Reference Brands: Dramamine(US & EU)
View DetailsScopolamine (Hyoscine) Transdermal Patches
Strength:
1.5 mg
Form: Transdermal patch
Reference Brands: Transderm-Scop(US)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit